Université Catholique de Louvain
uclouvain.beTotal trials
141
Active
47
Phase 3
1
Total enrollment
32,610
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Arterial blood sample | — | — | — | — | — | 1 |
Next readouts
- 2028-01
Top conditions
- Healthy13
- Cerebral Palsy11
- Rheumatoid Arthritis4
- Stroke4
- Depression3
- Parkinson Disease3
- Cachexia3
- Low Back Pain3
Frequently asked questions about Université Catholique de Louvain
- How many clinical trials does Université Catholique de Louvain have on ClinicalTrials.gov?
- Université Catholique de Louvain is listed as the lead sponsor on 141 clinical trials in ClinicalTrials.gov, 47 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Université Catholique de Louvain's trials are in Phase 3?
- 1 of Université Catholique de Louvain's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Université Catholique de Louvain focus on?
- Université Catholique de Louvain's most-studied conditions on ClinicalTrials.gov are Healthy, Cerebral Palsy, Rheumatoid Arthritis, Stroke, Depression.
- When are Université Catholique de Louvain's next clinical trial readouts?
- Université Catholique de Louvain has 1 upcoming primary-completion readout tracked here; the soonest is “Assessment of GARP Expression in Acute and Chronic Coronary Syndrome”, expected around 2028-01.